AMLX — AMYLYX PHARMACEUTICALS INC

Ownership history in PRUDENTIAL FINANCIAL INC  ·  5 quarters on record

This page tracks every 13F SEC filing in which PRUDENTIAL FINANCIAL INC reported a position in AMYLYX PHARMACEUTICALS INC (AMLX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 10,155 -5,465 -35.0% 0.00% $138K $13.59
2025 Q2 ADDED 15,620 +420 +2.8% 0.00% $100K $6.41
2025 Q1 REDUCED 15,200 -4,200 -21.6% 0.00% $54K $3.54
2024 Q4 UNCHANGED 19,400 — 0% 0.00% $73K $3.78
2024 Q3 INITIATED 19,400 — — 0.00% $63K $3.24
% of Fund (quarterly)    AMLX price (monthly, adj. close)

Other funds also holding AMLX

As of 2025 Q4 — sorted by position size

Saturn V Capital Management LP 3Y 9.97% GREAT POINT PARTNERS LLC 3Y 7Y 6.85% Almitas Capital LLC 3Y 7Y 5.65% Commodore Capital LP 3Y 4.54% First Light Asset Management, LLC 3Y 7Y 3.1% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 2.73% TCG Crossover Management, LLC 3Y 2.5% Aldebaran Capital, LLC 3Y 2.15% PERCEPTIVE ADVISORS LLC 3Y 7Y 1.78% STEMPOINT CAPITAL LP 1.17%
← Back to PRUDENTIAL FINANCIAL INC Holdings